Journal list menu
IssueCancer Communications: Volume 44, Issue 3
295-452March 2024
Export Citations
Download PDFs
FEATURED COVER
Cover Image, Volume 44, Issue 3
- First Published: 22 March 2024
The cover image is based on the Review Article Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy by Bin Song et al., https://doi.org/10.1002/cac2.12520.
ISSUE INFORMATION
REVIEW
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
- Pages: 297-360
- First Published: 04 February 2024
ORIGINAL ARTICLES
NAT10-mediated ac4C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1
- Pages: 361-383
- First Published: 26 February 2024
SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation
- Pages: 384-407
- First Published: 26 February 2024
Targeting autophagy overcomes cancer-intrinsic resistance to CAR-T immunotherapy in B-cell malignancies
- Pages: 408-432
- First Published: 26 February 2024
LETTER TO THE EDITOR
AP4 induces JNK1 and a miR-22-3p/FOSL1 feed-forward loop to activate AP-1 and promote colorectal cancer metastasis
- Pages: 433-437
- First Published: 15 January 2024
LETTER TO THE JOURNAL
A novel strategy for treating oncogene-mutated tumors by targeting tumor microenvironment and synergistically enhancing anti-PD-1 immunotherapy
- Pages: 438-442
- First Published: 09 February 2024
LETTERS TO THE EDITOR
Multi-omic study to unmask genes involved in prostate cancer development in a multi-case family
- Pages: 443-447
- First Published: 21 November 2023
Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells
- Pages: 448-452
- First Published: 06 November 2023
Sign up for email alerts
Tools
More from this journal
Cancer collection based on different tumor types
Information for Authors
Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.
Impact Factors in Journal Citation Report (2018, Clarivate) are under the previous journal title Chinese Journal of Cancer.
Archival Content
To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.
Understanding Open Access
As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.
Relevant Open – Access Health Sciences journals
Aging AND Cancer (2020-Present)
Cancer Innovation (2022-Present)
Clinical and Translational Medicine (2012-Present)
MedComm (2020-Present)
MedComm – Oncology (2022-Present)